Raising the Bar in the Diagnosis of Non-Small Cell Lung Cancer (NSCLC): The Impact of Automated FISH Technology

  • Line Emilie Boje Zakariasen
  • , Mary Mathilde Knoblauch Fasting
  • , Sys Johnsen
  • , Svetlana Teplaia
  • , Sanni Charlotte Pedersen
  • , Filis Cramer Necip
  • , Camilla Qvist

Publikation: Bidrag til tidsskriftTidsskriftsartikelForskningpeer review

Abstract

The Met gene, which encodes a receptor tyrosine kinase, is crucial in cancer cell proliferation and survival. Fluorescence in situ hybridization (FISH) is vital for assessing MET-gene amplification in non-small cell lung cancer (NSCLC). Manual FISH assays are time-consuming and results are critical for treatment decision; automation could reduce turnaraound time. This study evaluates the potentional benefits of the automated FISH-system, Oncore Pro X (biocare Medical USA), by assessing factors including results, turnaround time, and cost.
OriginalsprogEngelsk
TidsskriftInternational Journal of Biomedical Laboratory Science
Vol/bind14
Udgave nummer1
Sider (fra-til)24-38
ISSN2308-7706
StatusUdgivet - 2025

Fingeraftryk

Dyk ned i forskningsemnerne om 'Raising the Bar in the Diagnosis of Non-Small Cell Lung Cancer (NSCLC): The Impact of Automated FISH Technology'. Sammen danner de et unikt fingeraftryk.

Citationsformater